Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000737207-19-000004
Filing Date
2019-11-19
Accepted
2019-11-19 16:04:58
Documents
54
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atrx-20190930x10q.htm 10-Q 883287
2 EXHIBIT 31.1 atrx-20190930xex311.htm EX-31.1 13674
3 EXHIBIT 31.2 atrx-20190930xex312.htm EX-31.2 13793
4 EXHIBIT 32.1 atrx-20190930xex321.htm EX-32.1 6718
5 EXHIBIT 32.2 atrx-20190930xex322.htm EX-32.2 6838
  Complete submission text file 0000737207-19-000004.txt   4320800

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atrx-20190930.xml EX-101.INS 675726
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atrx-20190930.xsd EX-101.SCH 38618
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atrx-20190930_cal.xml EX-101.CAL 57520
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atrx-20190930_def.xml EX-101.DEF 202200
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atrx-20190930_lab.xml EX-101.LAB 528207
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atrx-20190930_pre.xml EX-101.PRE 303121
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

EIN.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 191231151
SIC: 2834 Pharmaceutical Preparations